Medicare Enrolled

Dr. Matthew Sand, M.D.

Urology Physician · Atlanta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
275 COLLIER RD NW, Atlanta, GA 30309
4046054848
In practice since 2007 (19 years)
NPI: 1679779664 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sand? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sand

Dr. Matthew Sand is an urology physician in Atlanta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sand performed 1,664 Medicare services across 1,301 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sand received a total of $106,443 from 71 pharmaceutical and/or device companies across 593 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 50% volume in GA $106,443 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,664
Medicare services
Top 50% in GA for urology physician
1,301
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
559 $91 $370
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
196 $119 $561
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
192 $8 $23
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
180 $184 $652
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
80 $0 $3
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
74 $250 $929
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $62 $253
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
52 $63 $249
Transurethral prostate removal with electrocautery
This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding.
50 $574 $2,566
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
29 $331 $1,545
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
27 $104 $468
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
21 $173 $861
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
21 $47 $601
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
21 $82 $370
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
17 $77 $953
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
16 $9 $59
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
16 $11 $69
Ureteral stent insertion via cystoscopy
A tube is placed into the ureter using an endoscope inserted through the bladder.
14 $98 $832
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
13 $253 $1,037
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
12 $2 $9
Bladder stone removal, less than 2.5 cm
A procedure to crush, fragment, and remove bladder stones that are smaller than 2.5 centimeters.
11 $167 $3,736
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
11 $138 $691
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.1% high complexity
9.3% medium
82.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$106,443
Total received (2018-2024)
Avg $15,206/year across 7 years
Top 2% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
593
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$59,018 (55.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$31,514 (29.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,912 (14.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17,770
2023
$2,523
2022
$3,407
2021
$11,637
2020
$2,249
2019
$35,101
2018
$33,756

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Richard Wolf Medical Instruments Corp.
$8,391
Ambu A/S
$6,629
Boston Scientific Corporation
$448
Ambu Inc.
$323
Medtronic, Inc.
$275
Sumitomo Pharma America, Inc.
$240
ABBVIE INC.
$178
Endo USA, Inc.
$159
Teleflex LLC
$158
PROCEPT BioRobotics Corporation
$85
Endo Pharmaceuticals Inc.
$74
Bayer Healthcare Pharmaceuticals Inc.
$71
Astellas Pharma US Inc
$65
Merck Sharp & Dohme LLC
$53
Stryker Corporation
$53
ConvaTec Inc.
$48
Myriad Genetic Laboratories, Inc.
$45
PFIZER INC.
$42
C. R. Bard, Inc. & Subsidiaries
$41
DENTSPLY IH AB
$35
Dendreon Pharmaceuticals LLC
$33
Smith+Nephew, Inc.
$31
Blue Earth Diagnostics Limited
$30
Janssen Biotech, Inc.
$28
180 Medical, Inc.
$26
Ferring Pharmaceuticals Inc.
$25
Calyxo, Inc.
$22
Tolmar, Inc.
$20
Olympus America Inc.
$19
LSI SOLUTIONS INC
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
AstraZeneca Pharmaceuticals LP
$18
COLOPLAST CORP
$18
Antares Pharma, Inc.
$18
Novartis Pharmaceuticals Corporation
$15
CIVCO Medical Instruments
$14
Top 3 companies account for 87.0% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus America Inc.
$58,922
Gyrus ACMI, Inc.
$12,239
Richard Wolf Medical Instruments Corp.
$8,576
Ambu A/S
$6,629
Boston Scientific Corporation
$3,664
Olympus Latin America, Inc.
$2,220
Olympus Corporation
$1,665
Medtronic, Inc.
$1,166
Teleflex LLC
$1,060
Blue Earth Diagnostics Limited
$815
Coloplast Corp
$776
Astellas Pharma US Inc
$638
PROCEPT BioRobotics Corporation
$594
Dornier MedTech America, Inc
$574
NeoTract Inc.
$513
Endo Pharmaceuticals Inc.
$508
Sumitomo Pharma America, Inc.
$417
BOSTON SCIENTIFIC CORPORATION
$405
Olympus Corporation of the Americas
$370
Ambu Inc.
$323
PFIZER INC.
$286
Palette Life Sciences, Inc.
$285
ABBVIE INC.
$271
DENTSPLY IH AB
$230
C. R. Bard, Inc. & Subsidiaries
$182
Dendreon Pharmaceuticals LLC
$174
Myovant Sciences Inc.
$169
Myriad Genetic Laboratories, Inc.
$163
Endo USA, Inc.
$159
KARL STORZ Endoscopy-America
$143
AbbVie Inc.
$126
180 Medical, Inc.
$121
COLOPLAST CORP
$118
Bayer Healthcare Pharmaceuticals Inc.
$113
Laborie Medical Technologies Corp.
$101
Covidien LP
$98
Photocure Inc
$98
UROVANT SCIENCES INC
$97
AstraZeneca Pharmaceuticals LP
$91
DENTSPLY IH Inc.
$91
Antares Pharma, Inc.
$86
Merck Sharp & Dohme LLC
$85
Axonics, Inc.
$81
SRS Medical Systems, Inc.
$72
Allergan Inc.
$70
AngioDynamics, Inc.
$68
Rochester Medical Corporation
$65
Bayer HealthCare Pharmaceuticals Inc.
$63
ConvaTec Inc.
$60
Allergan, Inc.
$54
Stryker Corporation
$53
Ferring Pharmaceuticals Inc.
$46
Axonics Modulation Technologies, Inc.
$45
Agiliti Surgical, Inc.
$40
AbbVie, Inc.
$39
Baxter Healthcare
$37
Travere Therapeutics, Inc.
$36
Smith+Nephew, Inc.
$31
Janssen Biotech, Inc.
$28
Calyxo, Inc.
$22
Tolmar, Inc.
$20
Progenics Pharmaceuticals, Inc.
$20
Integra LifeSciences Corporation
$20
LSI SOLUTIONS INC
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
UROGEN PHARMA, INC.
$17
MEDIVATION FIELD SOLUTIONS LLC
$15
Novartis Pharmaceuticals Corporation
$15
CIVCO Medical Instruments
$14
Egalet US Inc
$14
Retrophin, Inc.
$1
Top 3 companies account for 74.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 1788 · 4mm · ADSTILADRIN · AMS · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BIOFIX · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bipolar Disposables · CONTINENCE CARE · CVAC ASPIRATION SYSTEM · Cysview · EDEX · ELIGARD · ERLEADA · EVUSHELD · Emprint · FLOSEAL · Foot Switch for UES-40 · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL - FEMALE SUI · GENERAL - THERAPIES · GENERAL KIDNEY STONE DISEASE · GENTLECATH GLIDE · GRAFIX · GREENLIGHT HOPKINS II OPTIK 30 · General - Therapies · GentleCath · INTERSTIM · JELMYTO · JNW URTRAC · KEYTRUDA · Koelis TRINITY Fusion Biopsy System · LIGASURE · LITHOCLAST · LITHOVUE · LOFRIC · LUPRON DEPOT · LYNPARZA · LigaSure · LithoVue · Lithotripters & Accessories · LoFric · Lumenis Pulse 120H · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Nubeqa · ORGOVYX · Olympus · Olympus Accessories · Olympus Camera Heads · Olympus Cysto-Resection · Olympus Guidewires · Olympus Laser Devices · Olympus Resection Disposables · Olympus Stone Baskets and Retrievers · PENILE & TESTICULAR RECONSTRUCTN · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · REZUM · SPACEOAR · SPEEDICATH · SPRIX · Sonablate · Stenostent · TISSEEL · TITAN · TOVIAZ · TRIA · Thiola · Titan · URETERO-RENO VIDEOSCOPE · UROLIFT · UroCuff · UroLift · UroLift System · VISERA ELITE · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xpeeda DSL Fiber · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (55%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for urology physician in GA.

Looking for an urology physician in Atlanta?
Compare urology physicians in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
179
Per 100K population
16.8
County median income
$91,490
Nearest hospital
PIEDMONT HOSPITAL, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sand is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sand experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sand performed 559 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sand receive payments from pharmaceutical companies?
Yes. Dr. Sand received a total of $106,443 from 71 companies across 593 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sand's costs compare to other urology physicians in Atlanta?
Dr. Sand's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →